![]() |
|
|
Vol. 28, Issue 10, 1149-1152, October 2000
Dr. Margarete Fischer-Bosch Institute There is very limited knowledge about possible pharmacokinetic
interactions between opioid analgesics and nonsteroidal
antiinflammatory drugs (NSAIDs), which are commonly used in combination
for the treatment of chronic pain. The major metabolic pathway of the weak opioid codeine is glucuronidation to codeine-6-glucuronide. Therefore we investigated the influence of the NSAID diclofenac on the
formation of codeine-6-glucuronide in vitro, using human liver tissue
homogenate. The formation of codeine-6-glucuronide exhibited single
enzyme Michaelis-Menten kinetics with an average Vmax of 93.6 ± 35.3 pmol/mg/min. A
noncompetitive inhibition of codeine-6-glucuronidation by diclofenac
was observed with an average Ki of 7.9 µM.
These in vitro findings suggest that a pharmacokinetic interaction
occurs in vivo, which has to be confirmed by an interaction study in
human subjects. It can be speculated that in case of inhibition of
glucuronidation, the amount of codeine available for other pathways
especially O-demethylation to morphine is increased, resulting in higher morphine serum levels and therefore higher analgesic efficacy.
of Clinical
Pharmacology,
Stuttgart, Germany (S.A., O.v.R., U.H., M.E.)
Robert Bosch Hospital,
Department of Surgery,
Stuttgart,
Germany (K.-P.T.)
Internal Medicine VI-Clinical
Pharmacology
and Pharmacoepidemiology,
University of Heidelberg,
Germany
(G.M.)
This article has been cited by other articles:
![]() |
S. Takeda, Y. Kitajima, Y. Ishii, Y. Nishimura, P. I. Mackenzie, K. Oguri, and H. Yamada INHIBITION OF UDP-GLUCURONOSYLTRANSFERASE 2B7-CATALYZED MORPHINE GLUCURONIDATION BY KETOCONAZOLE: DUAL MECHANISMS INVOLVING A NOVEL NONCOMPETITIVE MODE Drug Metab. Dispos., August 1, 2006; 34(8): 1277 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Engtrakul, R. S. Foti, T. J. Strelevitz, and M. B. Fisher ALTERED AZT (3'-AZIDO-3'-DEOXYTHYMIDINE) GLUCURONIDATION KINETICS IN LIVER MICROSOMES AS AN EXPLANATION FOR UNDERPREDICTION OF IN VIVO CLEARANCE: COMPARISON TO HEPATOCYTES AND EFFECT OF INCUBATION ENVIRONMENT Drug Metab. Dispos., November 1, 2005; 33(11): 1621 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Uchaipichat, P. I. Mackenzie, X.-H. Guo, D. Gardner-Stephen, A. Galetin, J. B. Houston, and J. O. Miners HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID Drug Metab. Dispos., April 1, 2004; 32(4): 413 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. King, W. Tang, J. Ngui, T. Tephly, and M. Braun Characterization of Rat and Human UDP-Glucuronosyltransferases Responsible for the in Vitro Glucuronidation of Diclofenac Toxicol. Sci., May 1, 2001; 61(1): 49 - 53. [Abstract] [Full Text] [PDF] |
||||